p53 protein expression by hepatocarcinogens in the rat liver and its potential role in mitoinhibition of normal hepatocytes as a mechanism of hepatic tumour promotion

Carcinogenesis
H E van GijsselJ H Meerman

Abstract

The tumour suppressor gene p53 is expressed in response to DNA-damage; its protein product blocks cells in the G1-phase of the cell cycle. This gives cells additional time to repair their DNA-damage. However, it may trigger apoptosis if damage is too high. Loss of p53 function appears to be an important step in carcinogenesis because 50% of human tumours have lost functional p53. In order to study the role of p53 in experimental hepatocarcinogenesis, we determined the expression of p53 in rat liver in response to various hepatocarcinogenic and hepatotoxic compounds. Administration of hepatocarcinogenic compounds increased p53 protein levels in the liver as detected by immunoprecipitation followed by SDS-PAGE and Western blotting with ECL-detection. The hepatocarcinogens included N-hydroxy-2-acetylaminofluorene, aflatoxin B1, and diethylnitrosamine. Their structural analogues N-hydroxy-4-acetylaminobiphenyl and ethyl methane-sulphonate which are not hepatocarcinogenic, did not induce p53. Also, two hepatotoxic compounds (carbon tetrachloride, D-galactosamine) did not induce p53. Other compounds that induced p53 in the rat liver were 2-aminofluorene (administered by drinking water for two weeks) and tris-(2,3-dibromopropyl)phosph...Continue Reading

Citations

Jul 31, 2003·Life Sciences·Hilde E van GijsselJohn H N Meerman
Jun 5, 2003·Toxicon : Official Journal of the International Society on Toxinology·Roberto E GuzmanMaria T Runnegar
Aug 1, 1999·Toxicology in Vitro : an International Journal Published in Association with BIBRA·H HildebrandA Mahnke
Mar 31, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·H E van GijsselJ H Meerman
Sep 26, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·H E Van GijsselJ H Meerman
Feb 23, 2010·Doklady Biological Sciences : Proceedings of the Academy of Sciences of the USSR, Biological Sciences Sections·O A TimofeevaN A Setkov
Oct 10, 2012·BMC Complementary and Alternative Medicine·Rahmat A KhanSumaira Sahreen
Feb 25, 2011·Future Oncology·Yan Liu, Jiayuh Lin
Aug 18, 2009·Inhalation Toxicology·Jingfang XieZiqiang Meng
Dec 3, 2014·Developmental and Comparative Immunology·Weijie MuZhanjiang Liu
Jun 16, 2007·Gastroenterology·Hashem B El-Serag, K Lenhard Rudolph
Sep 18, 2007·Cell Biochemistry and Function·Adam Gesing, Malgorzata Karbownik-Lewinska
Dec 7, 2007·Journal of Cellular and Molecular Medicine·Elke UeberhamUwe Ueberham
Nov 1, 2005·Regulatory Toxicology and Pharmacology : RTP·Juli Bai, Ziqiang Meng
May 30, 2013·Journal of Hepatology·He-Xin YanQi-Long Ying
Feb 1, 2017·Journal of Drug Targeting·Fathia Zaki El SharkawiLaila Ahmed Rashed
Jan 16, 1999·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·R R de HaasH J Tanke
Jun 18, 2004·Toxicologic Pathology·Inmaculada Martín-BurrielAnnick Prenez
Dec 11, 1999·Carcinogenesis·J AubrechtR H Schiestl
Dec 9, 2010·The Oncologist·Arun J SanyalRiccardo Lencioni
Jun 23, 1998·The Journal of Biological Chemistry·G Zhou, M T Kuo
Sep 19, 2020·Naunyn-Schmiedeberg's Archives of Pharmacology·Heba TahaZeineb A Hassan
Jul 20, 2021·Journal of Ayurveda and Integrative Medicine·K N K RanasingheR P V J Rajapakse

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis